02291.HK
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
HKSE · Industrials · Specialty Business Services · CN
HKD 13.29
−0.08%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 527.9M | 471.6M | 325.9M | 247.7M |
| Cost of Revenue | 161.1M | 81.0M | 47.6M | 37.1M | 28.0M |
| Gross Profit | 895.3M | 447.0M | 424.0M | 288.8M | 219.7M |
| Operating Expenses | |||||
| R&D Expense | 113.7M | 58.1M | 58.0M | 62.1M | 53.9M |
| SG&A Expense | 262.7M | 55.5M | 48.9M | 39.8M | 92.3M |
| General & Admin Expense | 46.3M | 9.8M | 12.7M | 16.6M | 53.7M |
| Selling & Marketing Expense | 146.5M | 45.6M | 36.2M | 23.3M | 38.7M |
| Other Expenses | (39.6M) | 56.8M | 31.0M | 14.9M | 75.2M |
| Total Operating Expenses | 336.8M | 170.4M | 137.9M | 116.8M | 221.4M |
| Cost and Expenses | 497.9M | 251.4M | 185.5M | 167.2M | 249.4M |
| Operating Income (EBIT) | 558.4M | 276.5M | 286.1M | 158.7M | (1.7M) |
| Non-Operating | |||||
| Interest Income | 52.2M | 18.3M | 22.2M | 14.8M | 5.7M |
| Interest Expense | 291.3K | 116.6K | 164.6K | 204.0K | 19.0M |
| Net Interest Income | 51.9M | 18.2M | 22.0M | 14.6M | (13.3M) |
| Other Non-Op Income/Expense | 7.9M | (77.3K) | (44.2K) | 709.6K | (13.3M) |
| Non-Operating Income (excl Interest) | 1.9M | 19.7M | (120.0K) | (14.8M) | (5.7M) |
| EBT (Pre-Tax Income) | 566.4M | 276.5M | 286.1M | 173.3M | (15.0M) |
| Income Tax Expense | 76.8M | 36.7M | 40.5M | 21.8M | 4.8M |
| Bottom Line | |||||
| Net Income | 489.6M | 239.7M | 245.6M | 151.5M | (19.8M) |
| Earnings from Cont. Ops | 489.6M | 239.7M | 245.6M | 151.5M | (19.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 489.6M | 239.7M | 245.6M | 151.5M | (19.8M) |
| Per Share | |||||
| Basic EPS | HK$1.41 | HK$0.69 | HK$0.71 | HK$0.44 | (HK$0.06) |
| Diluted EPS | HK$1.41 | HK$0.69 | HK$0.71 | HK$0.44 | (HK$0.06) |
| Revenue Per Share | HK$3.05 | HK$1.52 | HK$1.36 | HK$0.94 | HK$0.76 |
| Shares | |||||
| Basic Shares Outstanding | 346.7M | 346.7M | 346.8M | 346.8M | 327.6M |
| Diluted Shares Outstanding | 346.7M | 346.7M | 346.8M | 346.8M | 327.6M |
| Profitability Metrics | |||||
| EBITDA | 617.4M | 292.6M | 288.1M | 189.2M | 18.8M |
| D&A | 60.8M | 35.8M | 1.8M | 15.7M | 14.9M |
| EBIT | 556.5M | 256.8M | 286.3M | 173.5M | 3.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026